About: Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.26 (-11.89%)
EIKN NASDAQ Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics, Inc. Common Stock share price
EIKN price activity
Last Price
$7.260
Change (24hr)
-0.98 USD (11.89%)
Volume
318.18K
Volume (4w avg)
-
Open
$8.07
Day Range
$7.20 - $8.07
Previous Close
$8.24
Last Trade
23 Oct, 8:14 pm GMT+0
Delayed
23 Oct, 8:14 pm GMT+0
EIKN price performance
Delayed
23 Oct, 8:14 pm GMT+0
EIKN Market Signals